Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets after over a decade of Copayment mechanism in Uganda

Moses Ocan, Winnie Nambatya, Caroline Otike, Loyce Nakalembe, Sam Nsobya
doi: https://doi.org/10.1101/2023.11.17.23298706

Article Information

doi 
https://doi.org/10.1101/2023.11.17.23298706
History 
  • November 18, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Moses Ocan1,*,
  2. Winnie Nambatya2,
  3. Caroline Otike3,
  4. Loyce Nakalembe4 and
  5. Sam Nsobya5
  1. 1Department of Pharmacology & Therapeutics, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala
  2. 2Department of Clinical Pharmacy, College of Health Sciences, Makerere University, P. O. Box 7072, Kampala
  3. 3Data Department, Joint Clinical Research Centre, Lubowa, P. O Box 10005, Kampala, Uganda
  4. 4Department of Pharmacology, Soroti University, P.O. Box 211, Soroti, Uganda
  5. 5Department of Pathology, College of Health Sciences, Makerere University, P.O. Box 7072, Kampala, Uganda
  1. ↵*Corresponding author: Moses Ocan, E-mail: ocanmoses{at}gmail.com; Tel: +256712234364
Back to top
Posted November 18, 2023.
Download PDF
Data/Code
Email
Availability, market share and price of quality assured artemisinin-based combination therapies in private drug outlets after over a decade of Copayment mechanism in Uganda
Moses Ocan, Winnie Nambatya, Caroline Otike, Loyce Nakalembe, Sam Nsobya
medRxiv 2023.11.17.23298706; doi: https://doi.org/10.1101/2023.11.17.23298706
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area